Hutch News

Hutch News

Stories tagged 'Multiple Myeloma'

Fred Hutch partners with new Allen Institute for Immunology

Multipartner initiative aims to map the immune system in health and disease

Dec. 12, 2018 | By Sabrina Richards / Fred Hutch News Service

Researchers from Fred Hutchinson Cancer Research Center will partner with the new Allen Institute for Immunology to chart the human immune system by harnessing big data and emerging technologies.

View story >


'Exciting' but early results in trial of immunotherapy for myeloma

Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease

Dec. 3, 2018 | by Susan Keown / Fred Hutch News Service

The patients were out of options to treat their advanced myelomas. Then, they enrolled on a new clinical trial of genetically reprogrammed immune cells called CAR T cells.

View story >


Standard myeloma treatment reveals itself as an immunotherapy

Mouse study shows how transplanting patients’ own healthy blood stem cells can curb cancer, opening door to better treatments

Oct. 9, 2018 | By Susan Keown / Fred Hutch News Service

Despite conventional wisdom, a standard treatment for myeloma — autologous transplant — may be a type of immunotherapy, new research shows.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 14, 2017

Fred Hutchinson Cancer Research Center has announced awards totaling $1 million to nine of its scientists through the Evergreen Fund, a unique grant program that supports homegrown research projects deemed attractive to potential commercial partners. This is the second year of Evergreen Fund awards. This is the second year of Evergreen Fund awards. The Hutch’s Business Development & Strategy office created the program in 2016 in an effort to encourage scientists to pursue creative ideas with commercial appeal. The goal is to speed research from the bench to the bedside while generating income from patent rights and partnerships with the business sector.

View story >


A new option for high-risk multiple myeloma?

Study of three-step treatment approach reopens question of donor bone marrow transplant

Nov. 9, 2017 | by Susan Keown / Fred Hutch News Service

A new study offers a clue for solving a long-standing controversy in multiple myeloma: namely, whether a bone marrow transplant from a donor could be beneficial for patients with this disease and, if so, for which patients.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 17, 2017

Dr. Damian Green awarded $3.2 million to test radioimmunotherapy for multiple myeloma; CVS Health Foundation teams up with Fred Hutch and SCCA to help cancer patients kick the habit; Dr. Nancy Davidson elected to 2017 Class of Fellows of AACR Academy; and Dr. Lee Hartwell receives Research!America award

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.